Vimarsana
Biggest News Aggregation in the World

Page 11 - Yield10 Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Yield10 Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Yield10 Bioscience Today - Breaking & Trending Today

Yield10 Bioscience Names Willie Loh, Ph.D., Former Cargill - Vimarsana News

Yield10 Bioscience Names Willie Loh, Ph.D., Former Cargill

WOBURN, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience...

Yield10 Bioscience Names Willie Loh, Ph.D., Former Cargill - Vimarsana News

Yield10 Bioscience Names Willie Loh, Ph.D., Former Cargill

WOBURN, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience...

Yield10 Bioscience (NASDAQ:YTEN) Coverage Initiated by Analysts at Lake Street Capital - Vimarsana News

Yield10 Bioscience (NASDAQ:YTEN) Coverage Initiated by Analysts at Lake Street Capital

Stock analysts at Lake Street Capital began coverage on shares of Yield10 Bioscience (NASDAQ:YTEN – Get Rating) in a report released on Thursday, The Fly reports. The firm set a “buy” rating and a $12.00 price target on the specialty chemicals company’s stock. Lake Street Capital’s price objective indicates a potential upside of 212.50% from […]

Yield10 Bioscience (NASDAQ:YTEN) Upgraded at Zacks Investment Research - Vimarsana News

Yield10 Bioscience (NASDAQ:YTEN) Upgraded at Zacks Investment Research

Yield10 Bioscience (NASDAQ:YTEN – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. According to Zacks, “Yield10 Bioscience, Inc. is an agricultural bioscience company. It focuses on the development of disruptive technologies for improvement in […]

Yield10 Bioscience (NASDAQ:YTEN) Upgraded to "Hold" by Zacks Investment Research - Vimarsana News

Yield10 Bioscience (NASDAQ:YTEN) Upgraded to "Hold" by Zacks Investment Research

Zacks Investment Research upgraded shares of Yield10 Bioscience (NASDAQ:YTEN – Get Rating) from a sell rating to a hold rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “Yield10 Bioscience, Inc. is an agricultural bioscience company. It focuses on the development of disruptive technologies for improvement in crop yield to enhance global […]